2008

2008

1. Weykamp C, John WG, Mosca A, et al. The IFCC Reference Measurement System for HbA1c: A 6-Year Progress Report. Clin Chem. 2008;54(2):240-8;

2. Caruso D, Scurati S, Roglio I, et al. Neuroactive steroid levels in a transgenic rat model of CMT1A neuropathy. J Mol Neurosci 2008;34(3):249-53;

3. Panteghini M. Enzymatic assays for creatinine: time for action. Clin Chem Lab Med 2008;46(4):567-72;

4. Mosca A, Paleari R, Galanello R, et al. IFCC Working Group on Standardization of HbA2. New analytical tools and epidemiological data for the identification of HbA2 borderline subjects in the screening for beta-thalassemia. Bioelectrochemistry 2008;73(2):137-40;

5. Delanghe JR, Cobbaert C, Galteau MM, et al. Truness verification of actual creatinine assays in the European market demonstrates a disappointing variability that needs substantial improvement. An international study in the framework of the EC4 creatinine standardization working group. Clin Chem Lab Med 2008;46(9):1319-25;

6. John WG, Nordin G, Panteghini M. What’s in name? Standardisation of HbA1c: a response. Clin Chem Lab Med 2008;46(9):1326-7;

7. Panteghini M, Bunk DM, Christenson RH, et al. IFCC Working Group on Standardization of Troponin I. Standardization of troponin I measurements: an update. Clin Chem Lab Med. 2008;46(11):1501-6.